Announced Mon, 11 May · 18:27 IST

We wish to inform you that our Board of Directors at their meeting held on 11.05.2026 had inter alia considered and grant approval to transfer the permission in the name of the Company ....

Business Updates View source PDF

KOVAI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-5.1%1-day move
₹5660.00
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-5.1-5.0-4.6-5.5-6.4-4.7-4.6+2.1+6.0
Up moveDown movePending
AI summary

Kovai Medical Center & Hospital's Board has approved the transfer of its Allied Health Sciences (AHS) Courses division to Dr NGP Research and Educational Trust via a slump sale for cash consideration of Rs. 84.54 lakhs. The AHS division contributed only Rs. 396.37 lakhs (0.29%) of the company's total turnover and had negative net worth of Rs. -339.13 lakhs for FY2025. The sale is driven by new regulatory requirements under the National Commission for Allied and Healthcare Professions Act, 2021, which would require additional infrastructure investment. The company wants to focus on core medical education programmes with higher returns. The buyer is a related party as promoter directors serve as trustees of the trust. The transaction is on arm's length basis with independent valuation. BTA will be executed before May 31, 2026, with completion expected by November 30, 2026.

Likely market impact

Minimal financial impact as the AHS division represents less than 0.3% of company revenue and was loss-making. The divestiture removes a small non-core division and allows management to focus on core healthcare and medical education services. No change in shareholding pattern.